Search filters

List of works by Jason K Sa

A phase II trial of tipifarnib for patients with previously-treated, metastatic urothelial carcinoma harboring HRAS mutations

scientific article published on 07 July 2020

A tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastoma

scientific article published on 10 September 2018

ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages

scientific article published on 12 June 2020

Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress GBM Tumor Growth

scientific article

Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy

scientific article published on 19 April 2016

Antitumor activity, pharmacokinetics, tumor-homing effect, and hepatotoxicity of a species cross-reactive c-Met antibody

scientific article published on 13 September 2017

Comparison of 1p and 19q status of glioblastoma by whole exome sequencing, array-comparative genomic hybridization, and fluorescence in situ hybridization

scientific article published on 29 March 2018

Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial

scientific article published on 25 January 2021

Comprehensive pharmacogenomic characterization of gastric cancer

scientific article published on 18 February 2020

Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma

scientific article published on 01 January 2019

Genomic and transcriptomic characterization of skull base chordoma.

scientific article

Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium.

scientific article published on 8 February 2018

Hypermutagenesis in untreated adult gliomas due to inherited mismatch mutations

scientific article published on 07 January 2019

Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma

scientific article published on 01 February 2019

Identification of transcriptome signature for predicting clinical response to bevacizumab in recurrent glioblastoma.

scientific article

In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma

scientific article

Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities

scientific article published on 03 July 2020

Involvement of DDX6 gene in radio- and chemoresistance in glioblastoma

scientific article published on 11 January 2016

Ly6G+ inflammatory cells enable the conversion of cancer cells to cancer stem cells in an irradiated glioblastoma model

scientific article published on 25 February 2019

MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas

scientific article published on 04 August 2020

Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma

scientific article published on 07 April 2021

Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor

scientific article published on 18 October 2018

PIP4K2A as a negative regulator of PI3K in PTENdeficient glioblastoma

scientific article published on 21 March 2019

Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy

scientific article published on 27 September 2018

Pharmacokinetics, Biodistribution, and Toxicity Evaluation of Anti-SEMA3A (F11) in In Vivo Models.

scientific article

Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer

scientific article published on 17 March 2020

Spatiotemporal genomic architecture informs precision oncology in glioblastoma

scientific article published on 6 March 2017

The combination of neoantigen quality and T lymphocyte infiltrates identifies glioblastomas with the longest survival

scientific article published on 23 April 2019

Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma

scientific article published on 26 August 2020

Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.

scientific article published on 28 July 2017

Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain.

scientific article published on 13 September 2017

Paulina is supported by:

About Paulina

Help